Results
1 -
3 of
3The vitamin D3 analog, ILX-23-7553, enhances the response to Adriamycin and irradiation in MCF-7 breast tumor cells, Cancer Chemotherapy and Pharmacology A phase I study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumors, Investigational New Drugs Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies, Investigational New Drugs